These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 3170507

  • 1. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
    Tai T, Kawashima I, Tada N, Dairiki K.
    J Biochem; 1988 Apr; 103(4):682-7. PubMed ID: 3170507
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
    Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO.
    Cancer Res; 1989 Jan 01; 49(1):191-6. PubMed ID: 2908845
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3.
    Tai T, Kawashima I, Furukawa K, Lloyd KO.
    Arch Biochem Biophys; 1988 Jan 01; 260(1):51-5. PubMed ID: 2449128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas.
    Hirabayashi Y, Higashi H, Kato S, Taniguchi M, Matsumoto M.
    Jpn J Cancer Res; 1987 Jun 01; 78(6):614-20. PubMed ID: 3112076
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.
    Ozawa H, Kawashima I, Tai T.
    Arch Biochem Biophys; 1992 May 01; 294(2):427-33. PubMed ID: 1567198
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibody responses to ganglio-series gangliosides in different strains of inbred mice.
    Kawashima I, Nakamura O, Tai T.
    Mol Immunol; 1992 May 01; 29(5):625-32. PubMed ID: 1584231
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. GD3 expression by cultured human tumor cells of neuroectodermal origin.
    He X, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD.
    Acta Neuropathol; 1989 May 01; 79(3):317-25. PubMed ID: 2609939
    [Abstract] [Full Text] [Related]

  • 13. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.
    Kotani M, Ozawa H, Kawashima I, Ando S, Tai T.
    Biochim Biophys Acta; 1992 Jul 21; 1117(1):97-103. PubMed ID: 1627599
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy.
    Brindel I, Preud'homme JL, Vallat JM, Vincent D, Vasquez JL, Jauberteau MO.
    Neurosci Lett; 1994 Nov 07; 181(1-2):103-6. PubMed ID: 7534889
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides.
    Fukuta S, Werkmeister JA, Burns GF, Ginsburg V, Magnani JL.
    J Biol Chem; 1987 Apr 05; 262(10):4800-3. PubMed ID: 2435716
    [Abstract] [Full Text] [Related]

  • 16. Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside.
    Brodin T, Hellström I, Hellström KE, Karlsson KA, Sjögren HO, Strömberg N, Thurin J.
    Biochim Biophys Acta; 1985 Dec 04; 837(3):349-53. PubMed ID: 3840699
    [Abstract] [Full Text] [Related]

  • 17. Isolation and characterization of gangliosides from Theileria sergenti.
    Watarai S, Sugimoto C, Hosotani-Kaihara K, Kobayashi K, Onuma M, Lee JT, Kushi Y, Handa S, Yasuda T.
    J Vet Med Sci; 1996 Nov 04; 58(11):1099-105. PubMed ID: 8959658
    [Abstract] [Full Text] [Related]

  • 18. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
    Watarai S, Kushi Y, Shigeto R, Misawa N, Eishi Y, Handa S, Yasuda T.
    J Biochem; 1995 May 04; 117(5):1062-9. PubMed ID: 8586620
    [Abstract] [Full Text] [Related]

  • 19. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma.
    Hirabayashi Y, Hamaoka A, Matsumoto M, Matsubara T, Tagawa M, Wakabayashi S, Taniguchi M.
    J Biol Chem; 1985 Oct 25; 260(24):13328-33. PubMed ID: 2414279
    [Abstract] [Full Text] [Related]

  • 20. Binding of monoclonal antibody A2B5 to gangliosides.
    Kundu SK, Pleatman MA, Redwine WA, Boyd AE, Marcus DM.
    Biochem Biophys Res Commun; 1983 Nov 15; 116(3):836-42. PubMed ID: 6651849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.